Inizio Engage and Nye Health Form Alliance to Enhance Patient Support
Inizio Engage and Nye Health have formed a strategic collaboration bringing together services to deliver a transformative patient support experience. This new integrated approach marries the patient support experience offered in Inizio Engage’s Patient solutions services with the advanced analytics and data integration of Nye Health’s digital platform. Together, the companies can address individual needs of patients through a unique combination of behavioral insights, patient data, digital technology, and clinical expertise. Armed with data-driven insights, they can effectively drive patient adherence and persistence through support services and see the impact on patient outcomes.
“This partnership feels like the logical next step to add maximum patient benefits to our customer engagements in patient support. By relying upon better data (including real-world sources) we can offer better insights, increased measurability, plus have the ability to adapt and optimize a configurable, platform-based approach to our clients,” said Kate Kelly, Managing Director UK & Ireland, Inizio Engage.
“The effective utilization of digital technology in patient support programs represents a huge opportunity that hasn’t yet been fully realized,” said Tom White, Chief Product Officer at Nye Health. “Together, we can bring benefits to the millions of patients living with a long-term condition, and to an increasingly stretched healthcare profession, as well as enable the pharmaceutical industry to more fully understand the impact and effectiveness of their treatments.”
Former CEO of Merck and PM360 Lifetime Achievement Winner Roy Vagelos and wife Diana make historic $400 million donation to Columbia University Research
In the biggest gift ever made to the medical school, Roy and Diana Vagelos have donated $400 million to Columbia University in support of biomedical science research and education. A principal function of the gift will be to significantly expand the mission of The Roy and Diana Vagelos Institute for Basic Biomedical Science, which was founded last year. The institute will now provide the infrastructure to unite cutting-edge research taking place in basic science departments, leading medical and graduate education programs, and research initiatives in clinical departments.
The gift will also support construction of a new biomedical research building, to be known as the Vagelos Innovation Laboratories, at 167th Street and Audubon Avenue, on Columbia University’s Washington Heights medical campus. This facility will provide more than 55,000 square feet of new laboratory space. Roy and Diana’s generous gift provides major support for the medical school’s programs in cell engineering and gene therapy, and will expand innovative collaborations that harness recent breakthroughs in new technologies.
“[Roy and Diana Vagelos] are unique benefactors guided by laudable values that became guiding principles for our school. Their sustained commitment to education, scientific research, and human health, in general—and to Columbia, in particular—is simply unmatched,” stated a Columbia University press announcement. “The impact of their philanthropy will extend far beyond Columbia and be felt for generations to come.”
AbelsonTaylor Group Launches AT Activate, a Full-Service Healthcare Media Agency
AbelsonTaylor Group has launched a full-service media agency, AT Activate, to provide one-stop, data-driven media strategy, planning, buying and analytics services to ensure that healthcare media campaigns hit their targets and deliver measurable business success for clients. AT Activate will leverage the full capabilities, advanced analytics expertise, and established media network of AbelsonTaylor Group. The end-to-end media services team will drive greater efficiency and provide more flexibility to support clients at various stages of media planning, buying, optimizing, and analytics programming.
The agency will also offer new proprietary in-house solutions, including Media Mix Modeling, which determines the optimal allocation of promotional investment across channels for maximum ROI; and an innovative Multi-Touch Attribution Model, which quantifies how much each touchpoint along the marketing journey contributes to conversion. Clients will have one-click access to a Reporting Suite with user-friendly dashboards to monitor campaign performance, market impact, and action-driven media.
“This evolution of our media services is just one more way AbelsonTaylor Group supports our brands on the most holistic level,” said Vice President of Media, Christie Volke. “We are entering a new era of psychographics and using our advanced tools and capabilities to understand target audiences and how they behave. Knowing the where, how, and why of a brand’s target interaction makes the difference between passive digestion and active engagement. We’re advancing our use of AI and other emerging technologies while strengthening our roots as a creative agency backed by a best-in-class media service.”
Survey Science Unveils AI-Powered Health Platform DxCheck Version 2.0
Survey Science, Inc. announced the launch of DxCheck Version 2.0, a groundbreaking health website leveraging AI for patient symptom analysis and education. The new release significantly enhances the platform’s capabilities with new features. It now leverages eight distinct AI models to ensure accuracy and speed in its diagnostic tools including an upgraded diagnostic assistant, health condition assessments, image analysis, a BMI calculator, and comprehensive physician-screened health articles.
Using the AI-powered tool, patients or physicians input symptoms in free-form text and DxCheck provides a list of potential health conditions which the patient might be diagnosed with once they see their doctor. By uploading patient images, DxCheck analyzes visible symptoms and easily interprets x-rays, CT scans, and PET scans, making valuable insights accessible to both patients and healthcare professionals. The site provides preliminary insights, helping patients understand possible health issues before consulting with a healthcare professional, along with in-depth educational content that covers various health conditions.
Chris Searles, President of DxCheck, said, “DxCheck is a high-intent, endemic health site designed for patient and caregiver engagement. We leverage AI in innovative ways to provide our audience with personalized and comprehensive health information based on the details they provide. By utilizing this zero-party data in our proprietary AI audience models, we can reach and connect with larger diagnosed audiences, ensuring unmatched reach and efficiency in targeted ad delivery for our pharmaceutical advertising partners.”
